.svg){kind=small}
Oct-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Is this your brand?
See your full sales and distribution data: where you sell, how you're priced, and how you rank against the brands next to you on the shelf.
See your brand's dataCarry this brand in your store?
Headset Retailer is free. Connect your POS and see what's selling and what's sitting.
Sign up freeMarket Insights Snapshot
In October 2026, Concentrates expanded to 68.07% share with year-over-year growth of 21.59% and month-over-month growth of 4.08%, while Capsules contracted to 29.62% share with a year-over-year decline of 53.49% despite a 10.42% month-over-month uptick. Topical, though only 2.30% of mix, posted a 786.19% year-over-year surge and a 1062.36% month-over-month jump, indicating a nascent contributor. Against brand-level sales down 23.05% year over year and an average price down 5.77%, the mix implies volume is consolidating in Concentrates as Capsules recede, with Topical acting as an emerging test that can offset category risk if momentum sustains.
The concentration in Concentrates alongside a 16th-place rank in British Columbia positions Stigma Grow as a mid-pack specialist whose 21.59% category growth outpaces brand-level decline of 23.05%, suggesting share defense within its lead category even as overall revenue contracts. The Capsules retrenchment of 53.49% year over year versus a 10.42% month-over-month bounce implies pricing or distribution pressure earlier in the year now stabilizing, while Topical’s 1062.36% month-over-month spike and 786.19% year-over-year rise, albeit from a 2.30% base, signals optionality to diversify; the strategic read is to lean into Concentrates where the brand holds rank 16 while selectively scaling Topical to reduce reliance on a single category without reigniting the Capsules drag.
Competitive Landscape
Stigma Grow sits at rank #17 in AB Concentrates in October 2026, down 2 positions year over year from #15 and 6 positions below its July-to-September three-month mark of #11, while its peak of #9 in June 2026 is now 8 spots higher than its current standing; in contrast, BoxHot held #1 year over year but posted a -19.6% sales change, and Dab Bods maintained #3 with a 72.0% sales increase, indicating that Stigma Grow’s downward rank drift of 2 places YoY amid competitors gaining double-digit percentage momentum suggests a share erosion risk unless mix or velocity is realigned to the faster-growing tiers.
Notable Products
Sales in October 2026 were highly concentrated, with Phoenix Tears RSO (1g) at 54.3% and Capsules adding 27.1%, meaning two items account for more than four fifths of the brand’s revenue. New launches were minimal at 0.7% of sales, so most of its sales ride on long-running staples.
Peer avg: average price of the same product type and package size in the same states that month.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
